guys, get in on PARD NOW! you will thank me later
Is there some kind of upcoming good news? Sounds like if any kind of approval is coming for their cancer drug, it'll be a long & slow process since they can't win on "it's more effective than the competition" but they may have a shot at "it has less side effects than others."
Why did it drop on Monday? That would have been painful.
Poniard Pharmaceuticals, Inc. Announces Pivotal Phase 3 SPEAR Trial Of Picoplatin In Small Cell Lung Cancer Did Not Meet Primary Endpoint
Monday, 16 Nov 2009 07:01am EST
Poniard Pharmaceuticals, Inc. announced that its pivotal Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial of picoplatin in the second-line treatment of small cell lung cancer (SCLC) did not meet its primary endpoint of overall survival. The analysis, based on 320 evaluable events (patient deaths), showed a hazard ratio of 0.82 with a p value of 0.089. The international, multi-center, randomized, controlled Phase 3 SPEAR trial was conducted under a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA). The trial evaluated the efficacy and safety of picoplatin as second-line therapy in 401 cancer patients with SCLC who were refractory to or who progressed within six months of first-line platinum-based therapy. Picoplatin administered as an intravenous infusion once every three weeks plus best supportive care (BSC) was compared to BSC alone. BSC was designed in accordance with the National Comprehensive Cancer Network's guidelines. The primary endpoint of the trial was overall survival. Other endpoints included overall response rate, progression-free survival, disease control rate and duration of response. The Statistical Analytical Plan of the trial, as agreed to in the SPA, was 90 percent powered to show a 33 percent reduction in risk in death for picoplatin treatment plus best supportive care (BSC) compared with BSC alone (hazard ratio of 0.67; p value of 0.05).
guys, get in on PARD NOW! you will thank me later
guys, get in on PARD NOW! you will thank me later
Day-trade only IMO. But there are many, many better candidates for day-trading.
guys, get in on PARD NOW! you will thank me later
LOL, I see we have a dead cat bounce investor among us. I am more or less 'get in before the good/bad news' type. Did you buy any NGSX, VVUS? You might do another dead cat bounce tomorrow with VVUS if they announce bad news tomorrow morning.
You sure like to speculate, lol. I'm sitting on the sidelines for the next few. ETFC is one of my few long positions.
I'm bacccccck ... ok guys, get into this stock NOW.
PWRM ... look up VRMLQ (it went from 0.05 to $9 in a matter of weeks. Now at $20).
PWRM has the same potential and the outlook is so much better than VRMLQ.
Look it up and see the news that was just put out this morning, I'm in this long.
I'm the same guy that picked out MGLG and SKNY a while ago. Of course I've lost money along the way just like any other investor.
ETFC is up, will AMTD finally bite?
I'm bacccccck ... ok guys, get into this stock NOW.
PWRM ... look up VRMLQ (it went from 0.05 to $9 in a matter of weeks. Now at $20).
PWRM has the same potential and the outlook is so much better than VRMLQ.
Sell limit triggered, I am now sitting on 1,000 free shares. Even if it's a lotto play it's fine now!
waiting for the conference tomorrow. im holding at 1610! hahaha, not much but hey if it's like that other stock i mentioned, that's $10k
One can never be too cautious with penny stocks. I have a meager $25 profit even if the shares I'm holding go to zero.
yea, i didnt put up my life savings on this or any other penny stocks. it would be nice to make some money off a $100 investment. I'll check back in w/ you in a few weeks or earlier if we hear news.
waiting for the conference tomorrow. im holding at 1610! hahaha, not much but hey if it's like that other stock i mentioned, that's $10k